Trial Profile
Phase I trial of ALX 0962 for the treatment of severe allergic asthma.
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 27 May 2013
Price :
$35
*
At a glance
- Drugs Antiasthmatics (Primary)
- Indications Allergic asthma
- Focus Adverse reactions
- 27 May 2013 New trial record